Inventor · disambiguated record
Yaping Wang
Also filed as: WANG YAPING
22 granted patents·23 pending applications·168 citations·filing 2001–2025
94Inventor score
Files withDURECT CORP5INST GEOLOGY & GEOPHYSICS CAS4NOVARTIS AG4PHARMACIA CORP4BRAIN CHRISTOPHER THOMAS2
Top patents by PatentIndex Score
45 records- 0196US7419975B2Organic compoundsNOVARTIS AG·Filed 2005·Granted Sep 2, 2008·80 cites·10 claims
- 0295US11513088B1Method for comprehensively characterizing lower limit of oil accumulation of deep marine carbonate reservoirINST GEOLOGY & GEOPHYSICS CAS·Filed 2022·Granted Nov 29, 2022·15 cites·13 claims
- 0395US11435494B1Method for predicting oil accumulation depth limit of deep and ultra-deep marine carbonate reservoirsINST GEOLOGY & GEOPHYSICS CAS·Filed 2022·Granted Sep 6, 2022·9 cites·13 claims
- 0494US11499957B1Evaluation method for residual hydrocarbon of post- to over-mature marine source rocksINST GEOLOGY & GEOPHYSICS CAS·Filed 2021·Granted Nov 15, 2022·5 cites·2 claims
- 0588US9309252B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2014·Granted Apr 12, 2016·12 cites·18 claims
- 0686US7989441B2Organic compoundsNOVARTIS AG·Filed 2006·Granted Aug 2, 2011·8 cites·8 claims
- 0785US8957074B2Pyrrolopyrimidine compounds as inhibitors of CDK4/6BRAIN CHRISTOPHER THOMAS·Filed 2011·Granted Feb 17, 2015·9 cites·40 claims
- 0884US9434719B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHCAFERRO THOMAS RAYMOND·Filed 2014·Granted Sep 6, 2016·7 cites·16 claims
- 0981US6531494B1Gem-substituted αvβ3 antagonistsPHARMACIA CORP·Filed 2001·Granted Mar 11, 2003·10 cites·15 claims
- 1080US9688672B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2016·Granted Jun 27, 2017·2 cites·14 claims
- 1175US2023372361A1Use of oxygenated cholesterol sulfates for treating inflammatory conditionsDURECT CORP·Filed 2021·Application pending·0 cites
- 1274US2023233580A1Use of oxygenated cholesterol sulfates for cancers and non-cancerous transformations related to epstein-barr virusDURECT CORP·Filed 2021·Application pending·0 cites
- 1374US2023285416A1Use of oxygenated cholesterol sulfates for treating at least one of insulin resistance, diabetes, and prediabetesDURECT CORP·Filed 2021·Application pending·0 cites
- 1474US2023293551A1Use of oxygenated cholesterol sulfates for treating autoimmune conditionsDURECT CORP·Filed 2021·Application pending·0 cites
- 1574US2023218639A1Use of oxygenated cholesterol sulfates for treating neurological conditions, neurodegenerative diseases, and addictionDURECT CORP·Filed 2021·Application pending·0 cites
- 1667US7119100B2Oripavine derivatives and their uses as pharmaceuticalsZHEJIANG XIANJU PHARMACEUTICAL·Filed 2002·Granted Oct 10, 2006·8 cites·8 claims
- 1766US8207183B2Inhibitors of IAPPALERMO MARK G·Filed 2011·Granted Jun 26, 2012·1 cites·15 claims
- 1864US2025348959A1Ai-based hotel management system and methodAI REV CORP·Filed 2025·Application pending·0 cites
- 1964US2025214044A1Emulsification device and beverage machineKALERM TECH SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 2063US8598217B2Imidazole derivatives and their use as modulators of cyclin dependent kinasesHOWARD STEVEN·Filed 2010·Granted Dec 3, 2013·1 cites·18 claims
- 2162US2023235306A1Argonaute protein from eukaryotes and application thereofUNIV HUBEI·Filed 2023·Application pending·0 cites
- 2259US12421527B2Argonaute proteins from prokaryotes and applications thereofUNIV HUBEI·Filed 2022·Granted Sep 23, 2025·0 cites·6 claims
- 2359US2014275083A13-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idhCAFERRO THOMAS RAYMOND·Filed 2014·Application pending·0 cites
- 2458US7115596B2Thiazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Granted Oct 3, 2006·1 cites·6 claims
- 2557US10112931B23-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDHNOVARTIS AG·Filed 2017·Granted Oct 30, 2018·0 cites·11 claims
- 2654US2023056738A1Evaluation method for hydrocarbon expulsion of post- to over-mature marine source rocksINST GEOLOGY & GEOPHYSICS CAS·Filed 2021·Application pending·0 cites
- 2752US2022133840A1Use of microcystin in preparation of drug for preventing or treating organ and tissue fibrosis diseasesNANJING UNIVERSITY OF TECHNOLOGY·Filed 2020·Application pending·0 cites
- 2850US2011281845A1Organic compoundsCHEN ZHUOLIANG·Filed 2011·Application pending·0 cites
- 2949US8338440B2Inhibitors of IAPPALERMO MARK G·Filed 2012·Granted Dec 25, 2012·0 cites·17 claims
- 3048US2010157548A1Foldable electrical devicesINVENTEC APPLIANCES SHANGHAI C·Filed 2009·Application pending·0 cites
- 3146US10658239B2Wafer dicing methodSEMICONDUCTOR MFG INT BEIJING CORP·Filed 2018·Granted May 19, 2020·0 cites·7 claims
- 3246US2004043994A1Gem-substituted alpha v beta 3 antagonistsFiled 2003·Application pending·0 cites
- 3345US2023139773A1Semiconductor structure and fabrication method thereofSEMICONDUCTOR MFG INT BEIJING CORP·Filed 2022·Application pending·0 cites
- 3444US11300620B2Gas-liquid dynamic model-based accurate lithium-ion battery SOC estimation methodUNIV JIANGSU·Filed 2017·Granted Apr 12, 2022·0 cites·10 claims
- 3544US2005004200A1Pyrazole compounds as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3643US2005043344A1Heteroarylalkanoic acids as integrin receptor antagonists derivativesPHARMACIA CORP·Filed 2003·Application pending·0 cites
- 3743US2019291234A1Grinding mechanism, and clean equipment for liquid crystal panelBOE TECHNOLOGY GROUP CO LTD·Filed 2018·Application pending·0 cites
- 3841US7230156B2Method for preparing a sterile transgenic carpINST OF HYDROBIOLOGY CAS·Filed 2005·Granted Jun 12, 2007·0 cites·5 claims
- 3941US2019275103A1Use of Microcystin in Preparation of Drug for Preventing or Treating Organ and Tissue Fibrosis DiseasesNANJING UNIVERSITY OF TECHNOLOGY·Filed 2017·Application pending·0 cites
- 4041US2009111994A1Method for The Production of LosartanRATIOPHARM GMBH·Filed 2006·Application pending·0 cites
- 4141US2009156851A1Ferrocene-Diphosphine LigandsWEISSENSTEINER WALTER·Filed 2006·Application pending·0 cites
- 4240US2016237030A1Synthetic intermediate of maxacalcitol, preparation method therefor and use thereofZHEJIANG HISUN PHARM CO LTD·Filed 2014·Application pending·0 cites
- 4338US9346770B2Compounds having activating effect on subtypes of peroxisome proliferator-activated receptors and its preparation method and usesWANG YAPING·Filed 2011·Granted May 24, 2016·0 cites·7 claims
- 4437US2008114045A1Process for the Production of CandesartanGRAF ARCO STR 3·Filed 2005·Application pending·0 cites
- 4533US11286174B2System for supplying heat by means of stratum coal in-place slurrying and method for supplying power generation heat by means of stratum coal in-place slurryingZHEJIANG LUTE ENERGY TECH CO LTD·Filed 2017·Granted Mar 29, 2022·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →